Analyst Geoff Meacham downgraded the biotech name to sell.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Moderna has been on a tear since mid-August. Citi now sees it plunging 60%
